Nanobiotix Stock (NASDAQ: NBTX) stock price, news, charts, stock research, profile.
Open | $7.220 |
Close | $7.230 |
Volume / Avg. | 1.741K / 37.076K |
Day Range | 7.190 - 7.410 |
52 Wk Range | 4.550 - 11.000 |
Market Cap | $343.441M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nanobiotix (NASDAQ: NBTX) through any online brokerage.
Other companies in Nanobiotix’s space includes: Macrogenics (NASDAQ:MGNX), Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
The latest price target for Nanobiotix (NASDAQ: NBTX) was reported by Leerink Partners on Friday, December 8, 2023. The analyst firm set a price target for 11.00 expecting NBTX to rise to within 12 months (a possible 50.89% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Nanobiotix (NASDAQ: NBTX) is $7.29 last updated May 14, 2024 at 9:17 AM EDT.
There are no upcoming dividends for Nanobiotix.
Nanobiotix’s FY earnings are confirmed for Wednesday, April 24, 2024.
There is no upcoming split for Nanobiotix.
Nanobiotix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.